Persevere Trial-Triple Negative Breast Cancer

Persevere Trial-Triple Negative Breast Cancer A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients Please email or message the team directly with questions.

This is a Public page created for awareness of the PERSEVERE Clinical Trial. Respecting patient privacy and confidentiality is important to the study team, for doctor-patient relationships, and public trust in medical professionals. Please feel free to like, follow, and share this content at your own discretion.

Address

Indianapolis, IN
46202

Website

Alerts

Be the first to know and let us send you an email when Persevere Trial-Triple Negative Breast Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Persevere Trial-Triple Negative Breast Cancer:

Shortcuts

Share

Category